Role Description The Associate Director, Market Access, Germany is responsible for defining and executing the market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access, in Germany, this role helps to shape business strategies, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities. The incumbent will partner with regional and global commercial, HEOR, and medical affairs teams to deliver launch activities by providing access insights, developing evidence-based HTA, Pricing & Reimbursement dossiers and tools, engaging with market access and public affairs stakeholders as well as participating in pricing strategy activities, and drive the activities to deliver access results supporting the overall success of the product launches. Responsibilities - Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the German healthcare system. - HTA & Pricing Filings: Lead preparation and submission of value dossiers, benefit assessments (e.g., AMNOG/G-BA) and pricing negotiations with statutory health insurance decision makers (e.g., GKV-SV). - Value Communication: Translate clinical and economic evidence into compelling value communications tailored for German payers. - External Stakeholder Engagement: Build and maintain strong relationships with key external stakeholders (payers, HTA authorities, policy influencers). - Cross-Functional Collaboration: Work with Global and EU Region Market Access teams to align local access strategy with broader European and corporate objectives. - Participation in negotiations with all levels of national payers. - Collaborate with internal functions to develop innovative pricing and value-based contracting models to optimize the acceleration of reimbursement approvals. - Policy Monitoring: Monitor health policy developments, HTA processes and local reimbursement environments to inform strategy. - Drive access and value related projects such as landscape assessments, payer market research, payer advisory boards and general guidance on local strategies. - Development of outreach and engagement plan for key payers and their influencers creating and maintaining a strong network. - Participate in early access planning of new products and indications, drive launch readiness for multiple oncology assets. Qualifications - Advanced degree (e.g., PhD in Life Sciences, Pharmacy, Health Economics, Public Health). - 8+ years experience in market access, pricing, reimbursement or health economics (pharma/biotech/market access consulting). - Proven AMNOG/benefit assessment experience, with deep understanding of payer decision-making in Germany. - Demonstrated success and experience supporting an oncology product pre-launch, launch and post-launch in Germany. - Demonstrated success in negotiating pricing and reimbursement conditions with public administrations and health authorities. - Strong stakeholder management and ability to collaborate with internal and external partners. - Excellent communication skills, both in person and virtual. - Scientific and solution-oriented mindset and capability to move and execute in a rapidly changing, ambiguous environment. - Strong understanding of local healthcare systems, customer dynamics, and reimbursement environments. - Strong commercial and strategic acumen. - Willingness to travel nationally and internationally. - Proven leadership and people management capabilities; demonstrated success in small but fast-growing, entrepreneurial commercial environment. Company Description Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors currently in clinical development include: - daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; - elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; - zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; - RMC-5127, a RAS(ON) G12V-selective inhibitor. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

• Build and develop a high integrity, high quality sales team and provide overall leadership to the team. • Responsible for meeting and/or exceeding assigned sales objectives and ensuring actions plans are aligned to the strategic initiatives of the brand. • Lead regional sales force activities including hiring, training, performance evaluation and development while ensuring compliance to corporate policies. • Ensure each employee is trained on, and effectively implements, customer education. • Communicate most current knowledge of the industry and competitor products to regional teams. • Ensure participation in industry related trade shows, meetings, conferences, etc. • Analyze sales and customer data to ensure appropriate resources are deployed in the region. • Allocate and manage the region's budget and utilization of promotional resources. • Ensure strong, consistent performance that consistently meet or exceed brand objectives and product sales goals while consistently demonstrating accountability for all results.

• Conducting discussions related to aligned therapeutic areas, disease states, and general corporate overviews • Collaborating and communicating cross-functionally with respect to assigned Thought Leaders in order to ensure strategic and tactical cohesiveness • Plan and complete key thought leader engagements and senior executive encounters at local, regional and national conferences, POAs, in field engagements, and other venues in a complaint manner • Act as a liaison between thought leaders and home office cross-functional teams • Assisting with on-label key thought leader development, including speakers, with approved decks and materials • Facilitating certain speaker logistical and scheduling activities and working cross functionally to ensure timely communication • Providing feedback on GI Franchise and brand-related marketing strategies/materials to commercial leadership • Providing advisory board participant recommendations, and attending advisory boards where needed • Facilitate speaker bureau management, speaker recommendations and including contracting when requested • Follow and be knowledgeable of all laws, regulations and corporate policies

• Provides educational support to HCPs, nurses, and APPs regarding dosing/administration, adverse event and adverse event management regarding our approved Multiple Myeloma bispecific antibody when a clear educational need has been identified. • Appropriately collaborates with internal cross-functional partners, including field sales, training, marketing, thought leader liaisons, oncology key account leaders, and medical affairs • Coordinates and implements strategic plans to support educational responsibilities • Interacts with HCPs, such as APPs (i.e., NP, PA), nurses, pharmacists, and other key stakeholders in the assigned geography to ensure they are informed on current, key information about Regeneron’s Multiple Myeloma bispecific antibody • Conducts educational and in-service programs through 1:1 HCP and group presentations • Consistently works to improve disease state/product clinical knowledge/account management via ongoing approved NE training curriculum and appropriate cross-functional collaboration at POA meetings. • Completes all training requirements and proactively seeks to strengthen ongoing scientific knowledge regarding disease-state, competitive products, and healthcare trends • Maintains the highest level of integrity and acts per company compliance/legal guidelines at all times